Edge-to-edge Mitral Valve Repair in ATTR-CM

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 106 participants.

Also called NCT06075823

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 106 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06075823
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Germany, Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06075823. Randomized; no masking; primary purpose treatment. Start 2024-01-01 (actual); primary completion 2027-12-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Edge-to-edge Mitral Valve Repair in ATTR-CM
Acronym
MILLENNIAL
Condition
Mitral Regurgitation
Condition
ATTR-Cardiomyopathy
Condition
Edge-to-Edge Mitral Valve Repair
Intervention (Device)
TEER
Intervention (Other)
Optimal Medical Therapy
Lead sponsor
Medical University of Vienna (class: other)
Collaborator
Austrian Science Fund (FWF) (class: other)

Record details

Record id
cardio:ct-nct06075823
Content hash
994f01816e18a85c5a10568a50608bfa051323a307feaa92770fa72c18db5884